China's National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025
Policy / Regulatory

China’s National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU
CompanyDrug

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU

AccurEdit's ARTbase-A1 Base Editor Authorized by USPTO
CompanyDrug

AccurEdit’s ARTbase-A1 Base Editor Authorized by USPTO

Organon Acquires U.S. Rights to TOFIDENCE from Biogen
CompanyDeals

Organon Acquires U.S. Rights to TOFIDENCE from Biogen

Zhifei Bio's Trivalent Influenza Vaccine Approved for Clinical Trials in China
CompanyDrug

Zhifei Bio’s Trivalent Influenza Vaccine Approved for Clinical Trials in China

ChemPartner Plans Share Issuance to Raise Up to 316.3 Million Yuan
CompanyDeals

ChemPartner Plans Share Issuance to Raise Up to 316.3 Million Yuan

Peijia Medical and DSM-Firmenich Collaborate on Polymer Heart Valve Innovation
CompanyDeals

Peijia Medical and DSM-Firmenich Collaborate on Polymer Heart Valve Innovation

Henlius and Organon's HLX11 Biosimilar Clears EMA Validation Hurdle
CompanyDrug

Henlius and Organon’s HLX11 Biosimilar Clears EMA Validation Hurdle

Huadong Medicine's Semaglutide Injection Accepted for Review by China's NMPA
CompanyDrug

Huadong Medicine’s Semaglutide Injection Accepted for Review by China’s NMPA

Medtronic Partners with Methinks AI to Enhance Stroke Care in Emerging Markets
CompanyDeals

Medtronic Partners with Methinks AI to Enhance Stroke Care in Emerging Markets

Hengrui Pharmaceuticals Secures Clinical Trial Approval for HRS-9813 in IPF
CompanyDrug

Hengrui Pharmaceuticals Secures Clinical Trial Approval for HRS-9813 in IPF

Sino Medical Sciences Secures Malaysian Approval for Coronary Balloon Catheter
CompanyMedical Device

Sino Medical Sciences Secures Malaysian Approval for Coronary Balloon Catheter